NICE guidelines for management of lipids in type 2 diabetes mellitus: a practical interpretation

Kannel WB , McGee DL Diabetes and glucose tolerance as risk factors for cardiovascular disease: the Framingham study. Diabetes Care 1979;2:120-6.

UK Prospective Diabetes Study (UKPDS) Group. Effect of intensive blood glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet 1998;352:854-65.

Hansson L , Zachetti A. , Carruthers SG et al. Effects of intensive blood pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group . Lancet 1998;351:1755-62.

Pyorala K. , Pedersen TR , Kjekshus J. , Faergeman O. , Olsson AG , Thorgeirsson G. Cholesterol lowering with Simvastatin improves prognosis of diabetic patients with coronary heart disease. A subgroup analysis of the Scandinavian Simvastatin Survival study (4S). Diabetes Care 1997;20:614-20.

Gami AS , Montori VM , Erwin PJ , Khan MA , Smith SA for the Evidence in Diabetes Enquiry System (EVIDENS) Research Group. Systematic review of lipid lowering for primary prevention of coronary heart disease in diabetes. BMJ 2003;326:528-9.

McIntosh A. , Hutchinson A. , Feder G. et al. Clinical guidelines and evidence review for Type 2 Diabetes: Lipids Management. Sheffield: ScHARR, University of Sheffield, 2002:1-163.

Freemantle N. , Harvey EL , Wolf F. , Grimshaw JM , Grilli R. , Bero LA Printed educational materials: effects on professional practice and health care outcomes (Cochrane Review). In: The Cochrane Library. Oxford: Update Software, 2002;1.

Eccles M. , Freemantle N. , Mason J. North of England evidence-based guideline development project: Guideline for angiotensive converting enzyme inhibitors in primary care management of adults with symptomatic heart failure. BMJ 1998;316:1369-75.

Rubins HB , Robins SJ , Collins D. et al. Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial study Group. N Engl J Med 1999;341:410-18.

McIntyre M. , Kerr S. , Kennon B. , Small M. The Glasgow Chart - a simple method for calculation of cardiovascular risk in type 2 diabetes . Br J Diabetes Vasc Dis 2002;2:20810.

Peters TJ , Montgomery AA , Fahey T. How accurately do primary health care professionals use cardiovascular risk tables in the management of hypertension? Brit J Gen Pract 1999;49:987-8.

Abhimanya G. Dyslipoproteinaemia and diabetes. Endocrinol Metab Clin 1998;27:614

13. Heart Protection Study Collaborative group. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebocontrolled trial. Lancet 2002;360:7-22.

Haffner SM , Lehto S. , Ronnemaa T. , Pyorala K. , Laasko M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 1998;339:229-34.

Ballinger P. Do all diabetic patients need statins? A view from primary care. Br J Diabetes Vasc Dis 2003;3:58-61.

Grover SA , Coupal L. , Zowall H. , Alexander CM , Weiss TW , Gomes DRJ. How cost-effective is the treatment of dyslipidaemia in patients with diabetes but without cardiovascular disease? Diabetes Care 2001;24: 45-50.

Executive summary of the Third Report of the National Cholesterol Education Programme (NCEP III) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adults\ Panel III). JAMA 2001;285:2486-97.

Miettinen H. , Lehto S. , Salomaa V. et al. Impact of diabetes on mortality after the first myocardial infarction. The FINMONICA Myocardial Infarction Register Study Group. Diabetes Care 1998;21:69-75.

Gupta L. , Ward J. , Hayward R. Clinical practice guidelines in general practice: A national survey of recall, attitudes and impact. Med J Aust 1997;166:69-72.

Siriwardena AN Clinical guidelines in primary care: a survey of general Practitioners' attitudes and behaviour. Br J Gen Pract 1995;45:643-7.

Shaneyfelt T. , Mayo-Smith M. , Rothwangl J. Are guidelines following Guidelines? JAMA 1999;281:1900-05.

National Prescribing Centre. Implementing NICE Guidance. A Practical Handbook for Professionals. Abingdon, Oxon : Radcliffe Medical Press Ltd, ( 2001):1-148.

Hobbs FDR , Erhardt L. Acceptance of guideline recommendations and perceived implementation of coronary heart disease prevention among primary care physicians in five European attitudes about cardiovascular treatment (REACT) survey. Family Practice 2002;19:596-604.

Becker DM , Raqueno JV , Yook RM et al. Nurse mediated cholesterol management compared with enhanced primary care in siblings of individuals with premature coronary disease. Arch Intern Med 1998;158: 1533-9.

Shea S. , DuMouchel W. , Bahamonde L. A meta-analysis of 16 randomised controlled trials to evaluate computer-based clinical reminder systems for preventive care in the ambulatory setting. J Am Med Inform Assoc 1996;3:399-409.

Euroaspire I. and II Group : European Action on Secondary Prevention by Intervention to Reduce Events. Clinical reality of coronary prevention guidelines: a comparison of EUROASPIRE I and II in nine countries . Lancet 2001;357:995-1001.